UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
ASSETS
Cash and cash equivalents	$ 4,546	$ 5,295
Restricted cash and equivalents	137,523	135,537
Finance receivables	774,476	897,530
Less: Allowance for finance credit losses	(114,073)	(11,640)
Finance receivables, net	660,403	885,890
Finance receivables measured at fair value	1,559,697	1,444,038
Furniture and equipment, net	1,388	1,512
Deferred tax assets, net	58,375	15,480
Accrued interest receivable	8,795	11,645
Other assets	37,569	39,852
Total	2,468,296	2,539,249
Liabilities
Accounts payable and accrued expenses	56,932	47,077
Warehouse lines of credit	141,988	134,791
Residual interest financing	37,913	39,478
Securitization trust debt	2,091,642	2,097,728
Subordinated renewable notes	18,322	17,534
Total	2,346,797	2,336,608
COMMITMENTS AND CONTINGENCIES
Shareholders' Equity
Common stock, no par value; authorized 75,000,000 shares; 22,558,918 and 22,530,918 shares issued and outstanding at March 31, 2020 and December 31, 2019	71,792	71,257
Retained earnings	58,128	139,805
Accumulated other comprehensive loss	(8,421)	(8,421)
Total stockholders' equity	121,499	202,641
Total liabilities and stockholders' equity	2,468,296	2,539,249
Series A Preferred Stock [Member]
Shareholders' Equity
Preferred stock	0	0
Series B Preferred Stock [Member]
Shareholders' Equity
Preferred stock	$ 0	$ 0